Abstract
Numerous reports describe osteonecrosis after oral corticosteroid therapy. It is still uncertain if corticosteroid treatment alone or in combination with other factors leads to the development of this condition. The literature presents controversial clinical and experimental data. The most affected site for osteonecrosis is the femoral head and therefore our considerations are concentrated at this site. Oral corticosteroids are commonly used in dermatology, especially in the treatment of connective tissue diseases and hypersensitive diseases. This clinical review evaluates the relationship between and the onset of femoral head necrosis. Although osteonecrosis of the femoral head can be caused by various conditions such as trauma, excess alcohol and hemoglobinopathies, studies indicate that treatment with corticosteroids is the most common cause of the condition. There is some controversy on the role of underlying disease and total corticosteroid dose administered, in the development of osteonecrosis of the femoral head. MRI scans are used to establish an early diagnosis.
There are several surgical and nonsurgical options for disease management, dependent on the stage of disease, the age of the patient and other risk factors.
In general, the risk for osteonecrosis is considered to be low under oral corticosteroid therapy. So far, no data can establish a direct relationship, but data still strongly suggest an existing cause and effect relationship. Further investigations are necessary for example, a large controlled prospective long-term study, to further refine an association between the corticosteroid dose, the duration of treatment and other risk factors.
Dermatologists who prescribe oral corticosteroids, should always be aware of the potential risk of avascular femoral head necrosis and the patients should be informed about this severe complication of oral coricosteroid therapy.
Similar content being viewed by others
Notes
T1- and T2-weighted images MRI scans that are analyzed in different ways. The main difference is that T2-weighted images are more suitable to highlight fluids and are therefore more useful to diagnose fluids or fluid-like lesions.
References
Barnetson R.S., White A.D. The use of corticosteroids in dermatological practice. Med J Aust 1992; 156: 428–31
Mirzai R., Chang C., Greenspan A., et al. The pathogenesis of osteonecrosis and the relationship to corticosteroids. J Asthma 1999; 36: 77–95
Coombs R.R., Thomas R.W. Avascular necrosis of the hip. Br J Hosp Med 1994; 51: 275–80
Xenakis T.A., Beris A.E., Malizos K.K., et al. Total hip arthroplasty for avascular necrosis and degenerative osteoarthritis of the hip. Clin Orthop 1997; 341: 62–8
Papp G.M. Steroid-induced femoral head necrosis. J Am Osteopath Assoc 1977; 76: 752–7
Cushner F.O., Friedmann R.J. Osteonecrosis of the femoral head. Orthop Rev 1988; 17: 29–34
Frostick S.P., Wallace W.P. Osteonecrosis of the humeral head. Clin Rheumatol 1989; 3: 651–67
McNatt L.G., Lane D., Clark A.F. Angiostatic activity and metabolism of cortisol in the chorioallantoic membrane (CAM) of the chick embryo. J Steroid Biochem Mol Biol 1992; 42: 687–93
Wolf J.E., Guerin C., Laterra J., et al. Dexamethasone reduces vascular density and plasminogen activator activity in 9L rat brain tumors. Brain Res 1993; 604 (1–2): 79–85
Sambrook P.N., Hassall J.E., York J.R. Osteonecrosis after high dosage, short term corticosteroid therapy. J Rheumatol 1984; 11: 514–6
Cruess R.L. Cortisone-induced avascular necrosis of the femoral head. J Bone Joint Surg 1977; 59: 308–17
Powell E.T., Lanzer W.L., Mankey M.G. Core decompression for early osteonecrosis of the hip in high risk patients. Clin Orthop 1997; 225: 181–9
Wang G.J., Moga D.B., Riechemer W.G., et al. Cortisone induced bone changes its response to lipid clearing agents. Clin Orthop 1978; 130: 81–5
Wang G.J., Sweet D.E., Reger S.I., et al. Fat-Cell changes as a mechanism of Avascular Necrosis of the femoral head in cortisone-treated rabbits. J Bone Joint Surg 1977; 59: 729–36
Solomon L. Idiopathic necrosis of the femoral head: pathogenesis and treatment. Can J Surg 1981; 24: 573
Fisher D.E., Bickel W.H. Corticosteroid-induced Avascular Necrosis. A clinical study of seventy-seven patients. J Bone Joint Surg 1971; 53: 859–73
Glimcher M.J., Kenzora J.E. The biology of osteonecrosis of the human femoral head and its clinical implication. I. Tissue biology. Clin Orthop 1979; 138: 284–309
Glimcher M.J., Kenzora J.E. The biology of osteonecrosis of the humen femoral head and its complications. II. The pathologic changes in the femoral head as an organ and in the hip joint. Clin Orthop 1979; 139: 283–312
Glimcher M.J., Kenzora J.E. The biology of osteonecrosis of the human femoral head and its clinical complications. III. Discussion of the etiology and geneses of the pathologic sequelae: comment of treatment. Clin Orthop 1979; 140: 273–312
Wang G.J., Rawles J.G., Hubbard S.L., et al. Steroid-induced femoral head pressure changes and their response to lipid-clearing agents. Clin Orthop 1983; 174: 298–302
Gold E.W., Fox O.D., Weissfiels S., et al. Corticosteroid-induced avascular necrosis: an experimental study in rabbits. Clin Orthop 1978; 135: 272
Hurley R.M., Steinberg R.H., Patriquin H., et al. Avascular necrosis of the femoral head in childhood systemic lupus erythematosus. CMAJ 1974; 111: 781–4
Cruess R.L. Steroid-induced osteonecrosis: a review. Can J Surg 1981; 24: 567–71
Ficat R. Current concepts in osteonecrosis.Idiopathic bone necrosis of the femoral head: early diagnosis and treatment. J Bone Joint Surg 1985; 67: 3–9
Mitchell D.G., Rao V.M., Dalinka M.K., et al. Femoral head avascular necrosis: correlation of MR imaging, radiographic staging, radionuclide imaging and clinical findings. Radiology 1987; 162: 709–15
Sakamoto M., Shimizu K., Iida S., et al. Osteonecrosis of the femoral head: a prospective study with MRI. J Bone Joint Surg 1997; 79: 213–9
Vreden S.G., Hermus A.R., van Liessum P.A., et al. Aseptic bone necrosis in patients on glucocorticoid replacement therapy. Neth J Med 1991; 39: 153–7
Colwell Jr C.W., Robinson C.A., Stevenson D.D., et al. Osteonecrosis of the femoral head in patients with inflammatory arthritis or asthma receiving corticosteroids therapy. Orthopedics 1996; 19: 941–6
OBrien T.J., Mack G.R. Multifocal osteonecrosis after short-term high-dose corticosteroid therapy. A case report. Clin Orthop 1992; 279: 176–9
Grossmann S., Ganz R. Osteonecrosis following short-term, high-dosage steroid therapy. Schweiz Med Wochenschr 1991; 121: 635–41
Taylor L.J. Multifocal avascular necrosis after short-term high-dose steroid therapy. A report of three cases. J Bone Joint Surg 1984; 66: 431–3
Anderton J.M., Helm R. Multiple joint osteonecrosis following short-term steroid therapy. Case report. J Bone Joint Surg 1982; 64: 139–41
Hummer Jr C.D. Avascular necrosis of the capital femoral epiphysis in a child receiving corticosteroids: a case report. Clin Orthop 1977; 125: 65–7
Kubo T., Fijioka M., Yamazoe S., et al. Relationship between steroid dosage and osteonecrosis of the femoral head after renal transplantation as measured by magnetic resonance imaging. Transplant Proc 1998; 30: 3039–40
Lausten G.S., Jensen J.S., Olgaard K. Necrosis of the femoral head after renal transplantation. Acta Orthop Scand 1988; 59: 650–4
Morris P.J., Chan L., French M.E., et al. Low dose oral prednisolone in renal transplantation. Lancet 1982; 1: 525–7
Cole W.G., Neal B.W. Corticosteroids and avascular necrosis of the femoral head in childhood. Aust Paediatr J 1976; 12: 37–42
Nishiyama K., Okinaga A. Osteonecrosis after renal transplantation in children. Clin Orthop 1993; 195: 168–71
Migliaresi S., Picillo U., Ambrosone L., et al. Avascular osteonecrosis in patients with SLE: relation to corticosteroid therapy and anticardiolipin antibodies. Lupus 1994; 3: 41
Weiner E.S., Abeles M. Aseptic necrosis and glucocorticosteroids in systemic lupus erythematosus: a reevaluation. J Rheumatol 1989; 16: 604–8
Hanif I., Mahmoud H., Pui C.H. Avascular femoral head necrosis in pediatric cancer patients. Med Pediat Oncol 1993; 21: 655–60
Lieberman P., Patterson R., Kunske R. Complications of long-term steroid therapy asthma. J Allergy Clin Immunol 1972; 49: 329–36
Garino J.P., Steinberg M.E. Total hip arthoplasty in patients with avascular necrosis of the femoral head: a 2- to 10-year follow-up. Clin Orthop 1997; 334: 108–15
Wassenaar R.P., Verburg H., Taconis W.K., et al. Avascular osteonecrosis of the femoral head treated with a vascularized. Radiographics 1996; 16: 585–94
Hungerford D.S. Treatment of ischemic necrosis of the femoral head. Surgery of the Musculoskeletal System. (3). 1983. New York: Churchill Livingstone, (GENERIC) Ref Type: Serial (Book, Monograph)
Hopson C.N., Siverhus S.W. Ischemic necrosis of the femoral head: treatment by core depression. J Bone Joint Surg Am 1988; 70 (7): 1048–51
Camp J.F., Colwell C.W. Jr. Core decompression of the femoral head for osteonecrosis. J Bone Joint Surg Am 1986; 68 (9): 1313–9
Smith S.W., Fehring T.K., Griffin W.L., et al. Core decompression of the osteonecrotic femoral head. J Bone Joint Surg 1995; 77: 674–80
Wang G.J., Dughmann S.S., Reger S.I., et al. The effect of core decompression on femoral head blood flow in steroid-induced avascular necrosis of the femoral head. J Bone Joint Surg 1985; 67: 121–4
Van Laere C., Mulier M., Simon J.P., et al. Core decompression for avascular necrosis of the femoral head. Acta Orthop Belg 1998; 64: 269–72
Mont M.A., Hungerford D.S. Current concepts review: non-traumatic avascular necrosis of the femoral head. J Bone Joint Surg 1995; 77: 459–74
Merle d’ Aubigne R., Portel M., Mazabraud A., et al. Idiopathic necrosis of the femoral head in adtuls. J Bone Joint Surg Br 1965; 47: 612–33
Balal M.A., Reichelt A.. Clinical results of rotational osteotomy for treatment of avascular necrosis of the femoral head. Arch Orthop Trauma Surg 1996; 115: 80–4
Dinulescu I., Stanculescu D., Nicolescu M., et al. Long-term follow-up after intertrochanteric osteotomies for avascular necrosis of the femoral head. Bull Hosp Jt Dis 1998; 57: 84–7
Grecula M.J., Grigoris P., Schmalzried T.D. Endoprotheses for osteonecrosis of the femoral head. A comparison of four models in young patients. Int Orthop 1995; 3: 137–45
Fritsch P. Dermatolgie und Venerologie. Berlin: Springer 1998: 428–32
el Maghraoui A., Tabache F., Bezza A., et al. Femoral head osteonecrosis after topical corticosteroid therapy. Clin Exp Rheumatol 2001; 19 (2): 233
Kubo T., Kojima A., Yamazoe S., et al. Osteonecrosis of the femoral head that developed after long-term topical steroid application. J Orthop Sci 2001; 6 (1): 92–4
Tang S.C., Chan K.C., Chow S.P. Osteonecrosis of femoral head after topical steroid therapy. J R Coll Surg Edinb 1986 Oct; 31 (5): 321–3
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gebhard, K.L., Maibach, H.I. Relationship between Systemic Corticosteroids and Osteonecrosis. Am J Clin Dermatol 2, 377–388 (2001). https://doi.org/10.2165/00128071-200102060-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128071-200102060-00004